AMGN

Amgen

$438.12

+8.24 (+1.92%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 02.09.2026
$388.48
(-11.33%)
Strong Buy: 4
Buy: 10
Hold: 17
Sell: 2
Strong Sell: 1
Description:
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, UNITED STATES, 91320-1799
Fiscal year end:
December
Market capitalization:
$232 Billion
EBITDA:
$17.3 Billion
PERatio:
26.88
EPS:
15.99
Dividend per share:
$9.80
Dividend yield:
2.27%
Beta:
0.413

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+240%
How much will you get:
$3,404
Prices dates:
31-08-2016: $126.28 and 31-08-2026: $429.88